5//SEC Filing
WITHROW EDWARD W III 5
Accession 0001388410-22-000003
CIK 0001388410other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 5:15 PM ET
Size
13.1 KB
Accession
0001388410-22-000003
Insider Transaction Report
Form 5
Withrow Edward W III
10% Owner
Transactions
- Other
PREFERRED STOCK (SERIES A)
2021-11-06+396,339→ 796,071 total(indirect: By Huntington Chase Financial Group) - Other
COMMON STOCK
2021-11-06+15,921,420→ 72,430,792 total(indirect: By LLC) - Other
PREFERRED STOCK (SERIES A)
2011-09-30$2.75/sh+36,339$99,932→ 399,732 total(indirect: By Huntington Chase Financial Group) - Other
PREFERRED STOCK (SERIES A)
2021-11-06−796,071→ 0 total(indirect: By Huntington Chase Financial Group) - Disposition to Issuer
STOCK OPTION
2021-03-31−3,000,000→ 1,000,000 total(indirect: By LLC)Exercise: $0.25Exp: 2022-12-31→ COMMON STOCK (3,000,000 underlying)
Footnotes (4)
- [F1]Additional Series A Preferred shares acquired; not included in previous Form 5 for the year 12/31/2012. Total Series A Preferred shares held at 12/31/12 = 399,732.
- [F2]Cumulative dividends in kind on Series A Preferred Stock.
- [F3]Conversion of preferred stock into common stock at a ratio of 20 shares of common stock for each share of preferred stock.
- [F4]Unvested stock options canceled upon resignation of Reporting Person.
Documents
Issuer
PARALLAX HEALTH SCIENCES, INC.
CIK 0001388410
Entity typeother
Related Parties
1- filerCIK 0001305862
Filing Metadata
- Form type
- 5
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 5:15 PM ET
- Size
- 13.1 KB